Back to Archived Journals » Vaccine: Development and Therapy
Vaccine: Development and Therapy ceased publishing in November 2016. All new submissions can be made to Drug Design, Development and Therapy. All articles that have been published in Vaccine: Development and Therapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Vaccine: Development and Therapy
ISSN: 2230-2298
- View all (31)
- Volume 6, 2016 (5)
- Volume 5, 2015 (6)
- Volume 4, 2014 (6)
- Volume 3, 2013 (5)
- Volume 2, 2012 (6)
- Volume 1, 2011 (3)
Journal Articles:
- 31 records -
The new first-line defense: the potential of nasopharyngeal colonization in vaccine strategies
Chan WY, Cohen JM, Brown JS
Vaccine: Development and Therapy 2016, 6:47-57
Published Date: 17 October 2016
Management of visceral leishmaniasis with therapeutic vaccines
Rawat K, Yadav NK, Joshi S, Ratnapriya S, Sahasrabuddhe AA, Dube A
Vaccine: Development and Therapy 2016, 6:33-45
Published Date: 28 September 2016
RTS,S malaria vaccine development: progress and considerations for postapproval introduction
Asante KP, Adjei G, Enuameh Y, Owusu-Agyei S
Vaccine: Development and Therapy 2016, 6:25-32
Published Date: 20 June 2016
Tularemia vaccine development: paralysis or progress?
Sunagar R, Kumar S, Franz BJ, Gosselin EJ
Vaccine: Development and Therapy 2016, 6:9-23
Published Date: 4 May 2016
Pertussis vaccine in pregnant women: safety and uptake
Munoz FM
Vaccine: Development and Therapy 2016, 6:1-8
Published Date: 9 March 2016
Hendra and Nipah viruses: pathogenesis, animal models and recent breakthroughs in vaccination
Weingartl HM
Vaccine: Development and Therapy 2015, 5:59-74
Published Date: 28 September 2015
Development of a vaccine for Chlamydia trachomatis: challenges and current progress
Hafner LM, Timms P
Vaccine: Development and Therapy 2015, 5:45-58
Published Date: 17 August 2015
Current and future prophylactic vaccines for hepatitis C virus
Dunlop JI, Owsianka AM, Cowton VM, Patel AH
Vaccine: Development and Therapy 2015, 5:31-44
Published Date: 11 August 2015
Immunosenescence: implications for vaccination programs in the elderly
Loukov D, Naidoo A, Bowdish DME
Vaccine: Development and Therapy 2015, 5:17-29
Published Date: 6 August 2015
A database in ACCESS for assessing vaccine serious adverse events
Thomas RE, Jackson D
Vaccine: Development and Therapy 2015, 5:9-16
Published Date: 20 April 2015
Evaluating the safety and immunogenicity of yellow fever vaccines: a systematic review
Thomas RE
Vaccine: Development and Therapy 2015, 5:1-8
Published Date: 20 April 2015
Vaccines for metabolic diseases: current perspectives
Morais T, Andrade S, Pereira SS, Monteiro MP
Vaccine: Development and Therapy 2014, 4:55-72
Published Date: 2 September 2014
Challenges to developing effective streptococcal vaccines to prevent rheumatic fever and rheumatic heart disease
Sharma A, Nitsche-Schmitz DP
Vaccine: Development and Therapy 2014, 4:39-54
Published Date: 2 May 2014
Current progress toward vaccines against Toxoplasma gondii
Garcia JL, Innes EA, Katzer F
Vaccine: Development and Therapy 2014, 4:23-37
Published Date: 16 April 2014
Immunization and chemical conjugation of Bm95 obtained from Pichia pastoris enhances the immune response against vaccinal protein and Neisseria meningitidis capsular polysaccharide
Rodriguez-Valle M, Canan-Hadden L, Niebla O
Vaccine: Development and Therapy 2014, 4:15-22
Published Date: 7 March 2014
Changing epidemiology of hepatitis A virus in Indian children
Arankalle V, Mitra M, Bhave S, Ghosh A, Balasubramanian S, Chatterjee S, Choudhury J, Chitkara A, Kadhe G, Mane A, Roy S
Vaccine: Development and Therapy 2014, 4:7-13
Published Date: 18 January 2014
Immunogenicity and safety of live attenuated hepatitis A vaccine (Biovac-A™) in healthy Indian children
Bhave S, Ghosh A, Sapru A, Mitra M, Chatterjee S, Bhattacharya N, Kadhe G, Mane A, Roy S
Vaccine: Development and Therapy 2014, 4:1-6
Published Date: 19 December 2013
Melanoma vaccines: trials and tribulations
Dillman RO
Vaccine: Development and Therapy 2013, 3:57-78
Published Date: 10 October 2013
Review of recent literature on microneedle vaccine delivery technologies
Vrdoljak A
Vaccine: Development and Therapy 2013, 3:47-55
Published Date: 22 August 2013
Current research and clinical trials for a vaccine against Chikungunya virus
Singh P, Chhabra M, Mittal V, Sharma P, Rizvi MA, Chauhan LS, Rai A
Vaccine: Development and Therapy 2013, 3:35-46
Published Date: 9 August 2013
Forced degradation studies: an essential tool for the formulation development of vaccines
Hasija M, Li L, Rahman N, Ausar SF
Vaccine: Development and Therapy 2013, 3:11-33
Published Date: 13 June 2013
Key feasibility considerations when conducting vaccine clinical trials in Asia–Pacific countries
Lansang EZ, Tan K, Nayak S, Lee KJ, Wai K
Vaccine: Development and Therapy 2013, 3:1-9
Published Date: 19 March 2013
Cytolethal distending toxin as virulence factor, protective antigen, and target for vaccine development
Lagergård T, Keith J
Vaccine: Development and Therapy 2012, 2:51-60
Published Date: 6 December 2012
Assessment of chicken protection against Campylobacter jejuni infection by immunization with avirulent Salmonella enterica sv. Typhimurium strain producing Campylobacter CjaD/Pal protein
Łaniewski P, Lis M, Wyszyńska A, Majewski P, Godlewska R, Jagusztyn-Krynicka EK
Vaccine: Development and Therapy 2012, 2:43-50
Published Date: 31 August 2012
Realizing the promise of breast cancer vaccines
Jackson E, Soliman H
Vaccine: Development and Therapy 2012, 2:35-41
Published Date: 22 August 2012
Reasons for not having received influenza vaccination and its predictors in Canadians
Chen Y, Wu J, Yi QL, Laroche J, Wong T
Vaccine: Development and Therapy 2012, 2:23-33
Published Date: 13 August 2012
New recombinant vaccines for the prevention of meningococcal B disease
Taha MK, Deghmane AE
Vaccine: Development and Therapy 2012, 2:15-22
Published Date: 27 June 2012
Advances in the development of vaccines for dengue fever
Simmons M, Teneza-Mora N, Putnak R
Vaccine: Development and Therapy 2012, 2:1-14
Published Date: 4 May 2012
Recombinant Rhipicephalus appendiculatus gut (Ra86) and salivary gland cement (Trp64) proteins as candidate antigens for inclusion in tick vaccines: protective effects of Ra86 on infestation with adult R. appendiculatus
Saimo M, Odongo DO, Mwaura S, Vlak JM, Musoke AJ, Lubega GW, Bishop RP, van Oers MM
Vaccine: Development and Therapy 2011, 1:15-23
Published Date: 23 November 2011
The utility of human challenge studies in vaccine development: lessons learned from cholera
Shirley DT, McArthur MA
Vaccine: Development and Therapy 2011, 1:3-13
Published Date: 5 October 2011
A new forum to spread the word on vaccine research
Pasetti MF
Vaccine: Development and Therapy 2011, 1:1-2
Published Date: 2 May 2011